Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 2
2013 4
2014 5
2015 10
2016 11
2017 16
2018 8
2019 4
2020 4
2021 5
2022 4
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Results by year

Filters applied: . Clear all
Page 1
Psychostimulants for Children: Are We Over or Under Dosing?
Blum K, Dennen C, Carney PR, Gilley E, Thanos PK, Braverman ER, Baron D, Hanna C, Modestino EJ, Gold MS, Elman I, Badgaiyan RD. Blum K, et al. J Addict Psychiatry. 2023;7(1):1-4. Epub 2023 Apr 22. J Addict Psychiatry. 2023. PMID: 37560458 Free PMC article.
Why haven't we solved the addiction crisis?
Blum K, Bowirrat A, Gomez LL, Downs BW, Bagchi D, Barh D, Modestino EJ, Baron D, McLaughlin T, Thanos P, Ceccanti M, Elman I, Badgaiyan RD, Dennen C, Gupta A, Braverman ER, Gold MS. Blum K, et al. J Neurol Sci. 2022 Nov 15;442:120404. doi: 10.1016/j.jns.2022.120404. Epub 2022 Sep 2. J Neurol Sci. 2022. PMID: 36084363 Review.
Precision Behavioral Management (PBM) and Cognitive Control as a Potential Therapeutic and Prophylactic Modality for Reward Deficiency Syndrome (RDS): Is There Enough Evidence?
Madigan MA, Gupta A, Bowirrat A, Baron D, Badgaiyan RD, Elman I, Dennen CA, Braverman ER, Gold MS, Blum K. Madigan MA, et al. Int J Environ Res Public Health. 2022 May 24;19(11):6395. doi: 10.3390/ijerph19116395. Int J Environ Res Public Health. 2022. PMID: 35681980 Free PMC article. Review.
Hypothesizing in the Face of the Opioid Crisis Coupling Genetic Addiction Risk Severity (GARS) Testing with Electrotherapeutic Nonopioid Modalities Such as H-Wave Could Attenuate Both Pain and Hedonic Addictive Behaviors.
Gupta A, Bowirrat A, Gomez LL, Baron D, Elman I, Giordano J, Jalali R, Badgaiyan RD, Modestino EJ, Gold MS, Braverman ER, Bajaj A, Blum K. Gupta A, et al. Int J Environ Res Public Health. 2022 Jan 4;19(1):552. doi: 10.3390/ijerph19010552. Int J Environ Res Public Health. 2022. PMID: 35010811 Free PMC article.
Hypothesizing Nutrigenomic-Based Precision Anti-Obesity Treatment and Prophylaxis: Should We Be Targeting Sarcopenia Induced Brain Dysfunction?
Blum K, Gold MS, Llanos-Gomez L, Jalali R, Thanos PK, Bowirrat A, Downs WB, Bagchi D, Braverman ER, Baron D, Roy AK 3rd, Badgaiyan RD. Blum K, et al. Int J Environ Res Public Health. 2021 Sep 16;18(18):9774. doi: 10.3390/ijerph18189774. Int J Environ Res Public Health. 2021. PMID: 34574696 Free PMC article. Review.
Psychoactive Drugs Like Cannabis -Induce Hypodopaminergic Anhedonia and Neuropsychological Dysfunction in Humans: Putative Induction of Dopamine Homeostasis via Coupling of Genetic Addiction Risk Severity (GARS) testing and Precision Pro-dopamine Regulation (KB220).
Blum K, Morgan J, Cadet JL, Baron D, Carney PR, Khalsa J, Badgaiyan RD, Gold MS. Blum K, et al. Neurology (ECronicon). 2021 Apr;13(4):86-92. Epub 2021 Mar 31. Neurology (ECronicon). 2021. PMID: 34085060 Free PMC article.
High Genetic Addiction Risk Score (GARS) in Chronically Prescribed Severe Chronic Opioid Probands Attending Multi-pain Clinics: an Open Clinical Pilot Trial.
Moran M, Blum K, Ponce JV, Lott L, Gondré-Lewis MC, Badgaiyan S, Brewer R, Downs BW, Fynman P, Weingarten A, Cadet JL, Smith DE, Baron D, Thanos PK, Modestino EJ, Badgaiyan RD, Elman I, Gold MS. Moran M, et al. Mol Neurobiol. 2021 Jul;58(7):3335-3346. doi: 10.1007/s12035-021-02312-1. Epub 2021 Mar 8. Mol Neurobiol. 2021. PMID: 33683627 Free PMC article. Clinical Trial.
Biotechnical development of genetic addiction risk score (GARS) and selective evidence for inclusion of polymorphic allelic risk in substance use disorder (SUD).
Blum K, Bowirrat A, Baron D, Lott L, Ponce JV, Brewer R, Siwicki D, Boyett B, Gondre-Lewis MC, Smith DE, Panayotis K T, Badgaiyan S, Hauser M, Fried L, A R 3rd, Downs BW, Badgaiyan RD. Blum K, et al. J Syst Integr Neurosci. 2020 Aug;6(2):10.15761/JSIN.1000221. doi: 10.15761/JSIN.1000221. Epub 2019 Dec 19. J Syst Integr Neurosci. 2020. PMID: 33614164 Free PMC article.
68 results